Revenue
$198.00K
Fiscal year ended 2019-12-31Operating income
-$24.89M
Fiscal year ended 2019-12-31Free cash flow
-$24.85M
Fiscal year ended 2019-12-31WINDTREE THERAPEUTICS INC /DE/ (WINT) reported revenue of $198.00K and net income of -$27.48M for the fiscal year ended 2019-12-31. This page shows 6 annual periods of income statement, balance sheet and cash flow figures normalized from WINDTREE THERAPEUTICS INC /DE/’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Biological Products, (No Diagnostic Substances).
Income
| Metric | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 |
|---|---|---|---|---|---|---|
| Revenue | $198.00K | $1.79M | $1.48M | $2.04M | $987.00K | $2.84M |
| Cost of revenue | Unavailable | Unavailable | Unavailable | Unavailable | $929.00K | $2.67M |
| Gross profit | Unavailable | Unavailable | Unavailable | Unavailable | $58.00K | $164.00K |
| Operating income | -$24.89M | -$16.20M | -$22.55M | -$38.04M | -$39.83M | -$43.26M |
| Net income | -$27.48M | -$20.53M | -$18.45M | -$39.49M | -$55.17M | -$44.06M |
| Research & development | $12.69M | $10.56M | $17.38M | $31.70M | $28.89M | $26.69M |
| Weighted-average diluted shares | Unavailable | shares 4.49M | shares 1.03M | shares 8.33M | shares 6.97M | shares 6.14M |
| Pretax income | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Income tax expense | Unavailable | Unavailable | Unavailable | Unavailable | $0 | $0 |
| Diluted EPS | Unavailable | $-7.74 | $-24.14 | $-4.74 | $-7.98 | $-7.84 |
| Selling, general & administrative | $12.40M | $7.42M | $6.66M | $8.37M | $11.00M | $16.73M |
| General & administrative | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Selling & marketing | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Balance
| Metric | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $22.58M | $11.19M | $1.82M | $5.59M | $38.72M | $44.71M |
| Total assets | $118.98M | $119.40M | $3.35M | $9.70M | $44.38M | $47.50M |
| Current assets | $23.86M | $25.65M | $2.24M | $7.19M | $40.79M | $45.56M |
| Total liabilities | $44.04M | $51.28M | $27.27M | $38.53M | $36.11M | $28.30M |
| Current liabilities | $7.82M | $20.63M | $11.76M | $13.39M | $11.07M | $7.83M |
| Total equity incl. NCI | $74.94M | $68.11M | -$23.92M | -$28.83M | $8.27M | $19.20M |
| Temporary (mezzanine) equity | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Inventory | Unavailable | Unavailable | Unavailable | Unavailable | $0 | $27.00K |
| Accounts receivable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | $0 |
| Goodwill | $15.68M | $15.68M | Unavailable | Unavailable | Unavailable | Unavailable |
| Long-term debt | Unavailable | Unavailable | Unavailable | $25.00M | $25.00M | $20.30M |
| Accounts payable | $1.71M | $3.42M | $2.32M | $1.81M | $369.00K | $350.00K |
Cash flow
| Metric | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$24.66M | -$15.78M | -$21.04M | -$33.59M | Unavailable | Unavailable |
| Capital expenditures | $191.00K | Unavailable | $24.00K | $281.00K | $458.00K | $780.00K |
| Investing cash flow | $13.80M | -$13.73M | -$24.00K | -$254.00K | Unavailable | Unavailable |
| Financing cash flow | $21.77M | $38.74M | $17.30M | $709.00K | Unavailable | Unavailable |
| Net change in cash | $11.37M | $9.32M | -$3.77M | -$33.13M | -$5.99M | -$41.57M |
| Stock-based compensation | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Common dividends paid | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Common share repurchases | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Depreciation & amortization | Unavailable | Unavailable | $192.00K | $255.00K | $712.00K | $818.00K |
Derived
| Metric | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 |
|---|---|---|---|---|---|---|
| Free cash flow | -$24.85M | Unavailable | -$21.07M | -$33.87M | Unavailable | Unavailable |
| Gross margin | Unavailable | Unavailable | Unavailable | Unavailable | 5.9% | 5.8% |
| Operating margin | -12572.2% | -905.8% | -1518.4% | -1862.7% | -4035.9% | -1525.9% |
| FCF margin | -12552.5% | Unavailable | -1418.8% | -1658.7% | Unavailable | Unavailable |
| SBC / revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Current ratio | 3.05x | 1.24x | 0.19x | 0.54x | 3.69x | 5.82x |
| Revenue YoY growth | -88.9% | 20.4% | -27.3% | 106.9% | -65.2% | Unavailable |
| Net margin | -13876.3% | -1148.4% | -1242.2% | -1933.9% | -5589.7% | -1554.1% |
| R&D / revenue | 6407.6% | 590.7% | 1170.1% | 1552.6% | 2926.8% | 941.4% |
| CapEx / revenue | 96.5% | Unavailable | 1.6% | 13.8% | 46.4% | 27.5% |
| Long-term debt / equity | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Effective tax rate | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open WINT in the interactive workspace to inspect any figure back to its filing.
Source filings
10-Q · Filed 2025-11-19View SEC filing
10-Q · Filed 2025-08-19View SEC filing
10-Q · Filed 2025-05-15View SEC filing
10-K · Filed 2025-04-15View SEC filing
10-Q · Filed 2024-11-26View SEC filing
10-Q · Filed 2024-08-19View SEC filing
Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.